HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case.

Abstract
Systemic sclerosis sine scleroderma is a rare form of limited cutaneous scleroderma. These patients manifest without cutaneous involvement, but do not differ in its clinical or laboratory features and prognosis from classical systemic sclerosis. In the absence of cutaneous signs/symptoms, its diagnosis is delayed leading to morbidity. The exact prevalence of dystrophic calcification in systemic sclerosis sine scleroderma, though a feature of systemic sclerosis, is not known. Development of dystrophic calcification further aggravates patient's woes. This paper describes systemic sclerosis sine scleroderma in a 17-year-old girl diagnosed initially as seronegative juvenile rheumatoid arthritis. She developed progressively increasing disk-like masses of calcinosis over the gluteal regions, knee, elbow, and ankle joints fixed to the overlying skin associated with malaise, anorexia, and weight loss. There was no Raynaud's phenomenon, dysphagia, dyspnoea, sclerodermatous skin, sclerodactyly, telangectasias, or muscle tenderness/weakness. Digital pitted scars, elevated anticentromere antibody values, esophageal hypomotility, and fluffy calcification in subdermal soft tissues in gluteal regions and around wrist, hip, knees, heels, and ankle joints (without affecting the underlying structures) were detected. Therapy with diltiazem and magnesium/aluminum antacids was useful in resolving calcinosis.
AuthorsNand Lal Sharma, Vikram K Mahajan, Nitin Ranjan, Vikas Chander Sharma, Mudita Gupta
JournalClinical rheumatology (Clin Rheumatol) Vol. 29 Issue 2 Pg. 215-9 (Feb 2010) ISSN: 1434-9949 [Electronic] Germany
PMID19834761 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Calcium Channel Blockers
  • Diltiazem
Topics
  • Adolescent
  • Calcinosis (complications, diagnosis, drug therapy, pathology)
  • Calcium Channel Blockers (therapeutic use)
  • Diltiazem (therapeutic use)
  • Female
  • Humans
  • Scleroderma, Systemic (complications, diagnosis, drug therapy, pathology)
  • Skin (pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: